Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,850 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.
Scudeller L, Righi E, Chiamenti M, Bragantini D, Menchinelli G, Cattaneo P, Giske CG, Lodise T, Sanguinetti M, Piddock LJV, Franceschi F, Ellis S, Carrara E, Savoldi A, Tacconelli E. Scudeller L, et al. Among authors: ellis s. Int J Antimicrob Agents. 2021 May;57(5):106344. doi: 10.1016/j.ijantimicag.2021.106344. Epub 2021 Apr 20. Int J Antimicrob Agents. 2021. PMID: 33857539 Free article.
IV and oral fosfomycin pharmacokinetics in neonates with suspected clinical sepsis.
Kane Z, Gastine S, Obiero C, Williams P, Murunga S, Thitiri J, Ellis S, Correia E, Nyaoke B, Kipper K, van den Anker J, Sharland M, Berkley JA, Standing JF. Kane Z, et al. Among authors: ellis s. J Antimicrob Chemother. 2021 Jun 18;76(7):1855-1864. doi: 10.1093/jac/dkab083. J Antimicrob Chemother. 2021. PMID: 33855449 Free PMC article. Clinical Trial.
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance.
Darlow CA, Docobo-Perez F, Farrington N, Johnson A, McEntee L, Unsworth J, Jimenez-Valverde A, Gastine S, Kolamunnage-Dona R, de Costa RMA, Ellis S, Franceschi F, Standing JF, Sharland M, Neely M, Piddock L, Das S, Hope W. Darlow CA, et al. Among authors: ellis s. Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0029321. doi: 10.1128/AAC.00293-21. Epub 2021 Jun 17. Antimicrob Agents Chemother. 2021. PMID: 33972238 Free PMC article.
Clinical management of severe infections caused by carbapenem-resistant gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations.
Carrara E, Savoldi A, Piddock LJV, Franceschi F, Ellis S, Sharland M, Brink AJ, Harris PNA, Levy-Hara G, Rohit A, Tsioutis C, Zayyad H, Giske C, Chiamenti M, Bragantini D, Righi E, Gorska A, Tacconelli E. Carrara E, et al. Among authors: ellis s. Clin Microbiol Infect. 2022 Jan;28(1):66-72. doi: 10.1016/j.cmi.2021.05.002. Epub 2021 May 8. Clin Microbiol Infect. 2022. PMID: 33975010 Free article.
In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol.
Righi E, Scudeller L, Chiamenti M, Abdelraouf K, Lodise T, Carrara E, Savoldi A, Menghin D, Pellizzari G, Ellis S, Franceschi F, Piddock L, Rebuffi C, Sanguinetti M, Tacconelli E. Righi E, et al. Among authors: ellis s. BMJ Open Sci. 2020 Jul 21;4(1):e100055. doi: 10.1136/bmjos-2019-100055. eCollection 2020. BMJ Open Sci. 2020. PMID: 35047691 Free PMC article.
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance.
Darlow CA, Farrington N, Johnson A, McEntee L, Unsworth J, Jimenez-Valverde A, Kolamunnage-Dona R, Da Costa RMA, Ellis S, Franceschi F, Sharland M, Neely M, Piddock LJV, Das S, Hope W. Darlow CA, et al. Among authors: ellis s. J Antimicrob Chemother. 2022 Apr 27;77(5):1334-1343. doi: 10.1093/jac/dkac038. J Antimicrob Chemother. 2022. PMID: 35170719 Free PMC article.
2,850 results